Application Nr Approved Date Route Status External Links
NDA020570 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications Quadramet ® Is Indicated For Relief Of Pain In Patients With Confirmed Osteoblastic Metastatic Bone Lesions That Enhance On Radionuclide Bone Scan.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Samarium Sm-153 Lexidronam Pentasodium

Comments